“…In medicinal science, increasing the solubility of active pharmaceutical ingredients (APIs) to improve their bioavailability is a core objective. Several methods have been established to address this concern, including the use of prodrugs [ 1 , 2 , 3 , 4 , 5 ], nanosuspensions, [ 6 , 7 , 8 , 9 ] or complexation of APIs [ 10 , 11 , 12 , 13 , 14 ], and modification of the solid API phase itself. The latter approach can be achieved through the formation of API salts, co-crystals, or amorphous systems to enhance the targeted drug’s solubility properties [ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 ].…”